LightCyber Reaps $20M To Advance Its Cyberattack Detection Services

LightCyber, a cybersecurity company that specializes in detecting hackers once they’ve breached the outer defenses of a data network, announced today it raised $20 million in a Series B financing round.

The venture round was led by Claltech, an Israeli division of New York-based global investment group Access Industries, and veteran security entrepreneur and investor Shlomo Kramer, who was a co-founder of Check Point Software. Prior financial backers Battery Ventures, Glilot Capital Partners, and Amplify Partners also invested. Claltech CEO Daniel Shinar will join Kramer on LightCyber’s board.

LightCyber, founded in 2012, aims to prevent malicious outsiders from lurking inside a network for months after silently slipping through a company’s perimeter defenses, such as firewalls. Once inside, hackers can further infiltrate a network, gaining more power to capture sensitive data, steal money, and do other harm.

The startup says it monitors users and “endpoints” such as mobile devices as part of its overall surveillance of a client’s network. The company is headquartered in Ramat Gan, Israel, and established a U.S. headquarters in Los Altos, CA, in 2015.

Detection of ongoing cyberattacks is one of the specialties developing in the highly diversified field of data security. Other threat detection startups include Boston-based Cybereason, also founded in 2012; and San Antonio, TX-based Infocyte, founded in 2014.

The new capital, which brings LightCyber’s total fundraising to $32 million, will be deployed to intensify sales and marketing efforts to support a global expansion, the company says.

Author: Bernadette Tansey

Bernadette Tansey is a former editor of Xconomy San Francisco. She has covered information technology, biotechnology, business, law, environment, and government as a Bay area journalist. She has written about edtech, mobile apps, social media startups, and life sciences companies for Xconomy, and tracked the adoption of Web tools by small businesses for CNBC. She was a biotechnology reporter for the business section of the San Francisco Chronicle, where she also wrote about software developers and early commercial companies in nanotechnology and synthetic biology.